Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF
Main Authors: | Fernández Lorente, Aymara, Acosta Brooks, Soraida, Neninger Vinageras, Elia, Barroso Alvarez, María del Carmen, Wilkinson Brito, Barbara, Troche Concepción, Mayelin, Martínez Pérez, Liana B, Viada González, Carmen E, Crespo Diaz, Tatiana, Casacó Parada, Angel Raymundo |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853575/ |
Similar Items
-
Evaluation of CIMAvaxEGF for the treatment of lung cancer: meta-analysis of controlled clinical trials
by: Carmen Viada
Published: (2017-02-01) -
CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos
by: Yoana Herrera Leiva, et al.
Published: (2017-04-01) -
CIMAvax-EGF®: Therapeutic Vaccine Against Non-small Cell Lung Cancer in Advanced Stages
by: Diana Rosa Fernández Ruiz, et al.
Published: (2017-02-01) -
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
by: Rodriguez, Pedro C, et al.
Published: (2011) -
Local signaling by the EGF receptor
by: Kempiak, Stephan J., et al.
Published: (2003)